Sec61β inhibitors constitute a distinctive chemical class of compounds characterized by their ability to selectively interact with the SEC61β subunit. The SEC61β subunit is an integral component of the SEC61 translocon complex located within the endoplasmic reticulum (ER) membrane. This translocon plays a crucial role in orchestrating the translocation of nascent polypeptides into the ER lumen during protein biogenesis. By specifically targeting SEC61β, these inhibitors disrupt the intricate process of protein translocation, potentially leading to perturbations in protein folding, assembly, and localization within the cellular environment.
The mechanism of action involves the binding of these inhibitors to SEC61β, modulating its function and thereby influencing the intricate network of cellular pathways that depend on proper protein trafficking. Ongoing research is focused on elucidating the precise interactions between these inhibitors and SEC61β, shedding light on their effects on cellular processes beyond protein translocation. The exploration of Sec61β inhibitors opens a new avenue of investigation into cellular mechanisms and their potential applications in diverse scientific contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
SecinH3 is a natural product-based compound that acts as a potent inhibitor of SEC61β. It was discovered through a high-throughput screen of small molecules and has been shown to induce apoptosis in certain cancer cell lines. | ||||||
CD 437 | 125316-60-1 | sc-202527 | 5 mg | $121.00 | ||
CD437 is a synthetic retinoid compound that has been reported to act as an inhibitor of the SEC61 translocon. It has demonstrated antitumor activity in various cancer models. | ||||||